Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
About this PQI
The purpose of this PQI is to discuss the clinical considerations of epcoritamab (Epkinly®) to optimize the outcomes for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 10/14/2025
PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia
Last Updated: 10/07/2025
PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events
Last Updated: 10/07/2025
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Last Updated: 09/19/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)
Last Updated: 10/04/2025
PQI in Action: Abiraterone acetate (Yonsa) Patient Selection and Management
Last Updated: 09/10/2025
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Last Updated: 09/10/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 08/25/2025
Treatment Support Kit: Mirdametinib
Last Updated: 06/10/2025
Treatment Support Kit: Abemaciclib
Last Updated: 04/11/2025
Treatment Support Kit: Temozolomide
Last Updated: 01/01/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
PQI in Action
Brentuximab Vedotin, Lenalidomide, and Rituximab
Last Updated: 11/10/2025
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Last Updated: 10/22/2025
Rituximab and Hyaluronidase
Last Updated: 10/14/2025
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
Patient Education Sheet
Patient Education Sheet
PQI in Action
Patient Education Sheet
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Last Updated: 10/22/2025
Rituximab and Hyaluronidase
Last Updated: 10/14/2025
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
Epcoritamab
Last Updated: 08/16/2025
PQI in Action
Patient Education Sheet
Immunotherapy
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
Epcoritamab
Last Updated: 08/16/2025
Up Close with Epcoritamab
Last Updated: 05/15/2025